Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial

PURPOSE: Pembrolizumab is active in melanoma, but activity in patients with untreated brain metastasis is less established. We present long-term follow-up of pembrolizumab-treated patients with new or progressing brain metastases treated on a phase II clinical trial (ClinicalTrials.gov identifier: N...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Kluger, Harriet M., Chiang, Veronica, Mahajan, Amit, Zito, Christopher R., Sznol, Mario, Tran, Thuy, Weiss, Sarah A., Cohen, Justine V., Yu, James, Hegde, Upendra, Perrotti, Elizabeth, Anderson, Gail, Ralabate, Amanda, Kluger, Yuval, Wei, Wei, Goldberg, Sarah B., Jilaveanu, Lucia B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2019
Soggetti:
Original Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354772/
https://ncbi.nlm.nih.gov/pubmed/30407895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00204
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi